Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Induction therapy with antithymocyte globulin before reperfusion.

Goldfarb SB, Gaynor JW, Fuller S, Kreindler J, Montenegro LM, Fynn-Thompson F, Visner G.

Ann Thorac Surg. 2010 Oct;90(4):1110-4; discussion 1114-5. doi: 10.1016/j.athoracsur.2010.05.074.

PMID:
20868797
2.

Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).

Koch A, Daniel V, Dengler TJ, Schnabel PA, Hagl S, Sack FU.

J Heart Lung Transplant. 2005 Jun;24(6):708-13.

PMID:
15949731
3.

The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab.

Burton CM, Andersen CB, Jensen AS, Iversen M, Milman N, Boesgaard S, Arendrup H, Eliasen K, Carlsen J.

J Heart Lung Transplant. 2006 Jun;25(6):638-47.

PMID:
16730569
4.

A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients.

Charpentier B, Rostaing L, Berthoux F, Lang P, Civati G, Touraine JL, Squifflet JP, Vialtel P, Abramowicz D, Mourad G, Wolf P, Cassuto E, Moulin B, Rifle G, Pruna A, Merville P, Mignon F, Legendre C, Le Pogamp P, Lebranchu Y, Toupance O, Hurault De Ligny B, Touchard G, Olmer M, Purgus R, Pouteil-Noble C, Glotz D, Bourbigot B, Leski M, Wauters JP, Kessler M.

Transplantation. 2003 Mar 27;75(6):844-51.

PMID:
12660513
5.

The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry.

Hachem RR, Edwards LB, Yusen RD, Chakinala MM, Alexander Patterson G, Trulock EP.

Clin Transplant. 2008 Sep-Oct;22(5):603-8. doi: 10.1111/j.1399-0012.2008.00831.x. Epub 2008 Apr 23.

PMID:
18435784
6.

Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.

Carlsen J, Johansen M, Boesgaard S, Andersen CB, Arendrup H, Aldershvilet J, Mortensen SA.

J Heart Lung Transplant. 2005 Mar;24(3):296-302.

PMID:
15737756
7.

Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation.

Bittner HB, Richter M, Kuntze T, Rahmel A, Dahlberg P, Hertz M, Mohr FW.

Eur J Cardiothorac Surg. 2006 Feb;29(2):210-5.

PMID:
16386921
8.

Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab.

Brock MV, Borja MC, Ferber L, Orens JB, Anzcek RA, Krishnan J, Yang SC, Conte JV.

J Heart Lung Transplant. 2001 Dec;20(12):1282-90.

PMID:
11744411
9.

Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring.

Djamali A, Turc-Baron C, Portales P, Leverson G, Chong G, Clot J, Mourad G.

Transplantation. 2000 Mar 15;69(5):799-805.

PMID:
10755529
10.
11.

Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.

Schulz T, Papapostolou G, Schenker P, Kapischke M.

Transplant Proc. 2005 Mar;37(2):1301-4.

PMID:
15848703
12.

Minimal acute cellular rejection remains prevalent up to 2 years after lung transplantation: a retrospective analysis of 2697 transbronchial biopsies.

Burton CM, Iversen M, Scheike T, Carlsen J, Andersen CB.

Transplantation. 2008 Feb 27;85(4):547-53. doi: 10.1097/TP.0b013e3181641df9.

PMID:
18347533
13.

Induction immunosuppression for lung transplantation with OKT3.

Wain JC, Wright CD, Ryan DP, Zorb SL, Mathisen DJ, Ginns LC.

Ann Thorac Surg. 1999 Jan;67(1):187-93.

PMID:
10086547
14.

Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.

Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.

Nephrology (Carlton). 2008 Feb;13(1):80-6. doi: 10.1111/j.1440-1797.2007.00866.x.

PMID:
18199109
15.

Induction therapy in lung transplantation: initial single-center experience comparing daclizumab and antithymocyte globulin.

Lischke R, Simonek J, Davidová R, Schützner J, Stolz AJ, Vojácek J, Burkert J, Pafko P.

Transplant Proc. 2007 Jan-Feb;39(1):205-12.

PMID:
17275507
16.

Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.

Oertel M, Sack U, Kohlhaw K, Lehmann I, Emmrich F, Berr F, Hauss J, Schwarz R.

Transpl Int. 2002 Oct;15(9-10):463-71. Epub 2002 Sep 24.

17.

Long-term evaluation of single bolus high dose ATG induction therapy for prophylaxis of rejection in live donor kidney transplantation.

Sheashaa HA, Hamdy AF, Bakr MA, Abdelbaset SF, Ghoneim MA.

Int Urol Nephrol. 2008;40(2):515-20.

PMID:
17978857
18.

A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation.

Mullen JC, Oreopoulos A, Lien DC, Bentley MJ, Modry DL, Stewart K, Winton TL, Jackson K, Doucette K, Preiksaitis J, Halloran PF.

J Heart Lung Transplant. 2007 May;26(5):504-10. Epub 2007 Mar 26.

PMID:
17449421
19.

Surveillance transbronchial lung biopsies: implication for survival after lung transplantation.

Swanson SJ, Mentzer SJ, Reilly JJ, Bueno R, Lukanich JM, Jaklitsch MT, Kobzik L, Ingenito EP, Fuhlbrigge A, Donovan C, McKee C, Boyle K, Fagan GP, Sugarbaker DJ.

J Thorac Cardiovasc Surg. 2000 Jan;119(1):27-37.

PMID:
10612758
20.

Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation.

Di Filippo S, Boissonnat P, Sassolas F, Robin J, Ninet J, Champsaur G, Bozio A.

Transplantation. 2003 Feb 15;75(3):354-8.

PMID:
12589158

Supplemental Content

Support Center